- This daily round-up provides you with a selection of the latest news and updates on the COVID-19 coronavirus pandemic, along with tips and tools to help you stay informed and protected.
- Top Stories: America Facing a “Unvaccinated Pandemic”; Two doses of Pfizer, AstraZeneca vaccines that are effective against the Delta variant; Hospitals in the Indonesian region of Papua are almost at full capacity.
1. How COVID-19 is affecting the world
Confirmed Cases of COVID-19 have exceeded 192 million worldwide, according to Johns Hopkins University. The number of confirmed deaths is more than 4.12 million. More than 3.73 billion Vaccination doses were managed worldwide according to Our World in Data.
Australia’s state of New South Wales has reported its largest daily increase in locally acquired COVID-19 cases this year – 124, up from 110 the day before.
It comes as Australian authorities warn against it Infections will continue to increase, despite weeks of tightened restrictions, and will take an economic toll.
A new study published in The Lancet says an estimated 1.5 million children around the world have the COVID-19 related death a parent, grandparent or other relative who has cared for them during the first 14 months of the pandemic.
President Joe Biden has pleaded again with Americans to get Vaccinated against COVID-19. “We have a pandemic of those who have not received a vaccination,” he said at an event in town hall.
President Biden also said the U.S. Centers for Disease Control is likely to advise unvaccinated children to Wearing masks when they go back to school after the summer break.
Hospitals in Indonesia’s Papua region are nearing full capacity amid an Increase in COVID-19 cases.
New York City requires COVID-19 vaccinations or weekly tests for workers in urban hospitals and clinics, announced Mayor Bill de Blasio. The new policy will take effect on August 2nd.
2. America faces a “pandemic of the unvaccinated”
The Pan American Health Organization (PAHO) has warned America is facing a pandemic of the unvaccinated, with countries with low vaccination rates seeing increases in COVID-19 cases.
“We are facing an unvaccinated pandemic and the only way to stop it is to expand vaccination,” said PAHO director Carissa Etienne at a weekly briefing. “Vaccines are critical even when no vaccine is 100% effective.”
Etienne also repeatedly called for vaccine donations and a fair distribution of relief supplies to those in need.
“We clearly need more vaccines and we need them now,” she said. “At the moment, vaccine donations are really the only way for many countries in our region to get the doses they need quickly.”
Only 15% of people in Latin America and the Caribbean are fully vaccinated, she said, adding that that figure obscures the fact that some countries like Honduras and Haiti haven’t even reached 1% vaccination yet.
As part of Work on identifying promising use cases for technologies to combat COVID, The Boston Consulting Group recently used contextual AI to analyze more than 150 million English-language media articles from 30 countries published between December 2019 and May 2020.
The result is a compendium of hundreds of technology use cases. The number of solutions will more than triple, providing better insight into the many uses of the technology for the COVID-19 response.
To see a full list of 200+ exciting technology use cases during COVID – please follow this link.
3. Two doses of Pfizer, AstraZeneca vaccines that are effective against the Delta variant
Two doses of the Pfizer / BioNTech or AstraZeneca COVID-19 vaccine are almost the same effective against the delta variant a new study has shown how they were against the previously dominated alpha variant.
The study, published in the New England Journal of Medicine, confirms the headline results from Public Health England in May.
“After receiving two doses of vaccine, the Delta variant found only modest differences in vaccine effectiveness compared to the Alpha variant,” researchers from Public Health England wrote in the study.
The study’s authors warned that vaccination with either vaccine is insufficient to achieve high levels of protection.